| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 19,059 | 15,818 | 17,257 | 18,336 | | Cost of Revenue | 6,855 | 4,980 | 5,705 | 8,297 | | | Gross Profit | 12,204 | 10,838 | 11,552 | 10,039 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,711 | 3,933 | 3,883 | 3,387 | | Non Recurring | 173 | (488) | 488 | 660 | | Others | 4,186 | 3,765 | 3,904 | 4,171 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,358 | 3,628 | 3,277 | 1,821 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,240) | 6,671 | 103 | 260 | | Earnings Before Interest And Taxes | 7,943 | 7,190 | 6,489 | 6,879 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 7,943 | 7,190 | 6,489 | 6,879 | | Income Tax Expense | 1,615 | 1,792 | 1,464 | 2,454 | | Minority Interest | (9) | (11) |
-
| (8) | | | | Net Income From Continuing Ops | 16,368 | 5,387 | 5,025 | 4,425 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,319 | 5,387 | 5,025 | 4,425 | | Preferred Stock And Other Adjustments |
-
| 7 | (7) |
-
| | | Net Income Applicable To Common Shares | $6,319 | $5,394 | $5,018 | $4,425 |
|
0.02% Nasdaq 0.00%
Income Statement
